Evaluation of an Organized Consultation "Return Home" of Patients With a Cancer (CREDO)
NCT ID: NCT02857400
Last Updated: 2022-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
667 participants
INTERVENTIONAL
2017-07-21
2022-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Subject will be randomized (1:1) as described below :
• Arm A (standard) : current standard of care ; connection documentation faxed to GP ( General practitioner) on the day of patient's discharge Arm B (experimental) : CREDO standard of care, organized consultation "return home" between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study
NCT06589414
Care Pathways and Disparities in Care for Older Patients With Cancer: Typology, Determinants and Effect on Prognosis ( PASSAGE )
NCT07092800
Interest of a Geriatric Intervention Plan Associated to a Comprehensive Geriatric Assessment on Autonomy, Quality of Life and Survival of Patients Aged 70 Years Old and More Surgically Treated for a Resectable Cancer (Thoracic, Digestive or Urologic). Randomized Multicentric Study
NCT02000011
Assessment of a Multidisciplinary Team Meeting (RCP) in Geriatric Oncology
NCT03662061
the Impact of Early Palliative Care on the Survival of Locally Advanced and / or Metastatic Cholangiocarcinoma Patients
NCT04415190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm A (standard)
current standard of care
connection documentation faxed to GP (General practitioner) on the day of patient's discharge
Arm B (experimental)
CREDO standard of care
organized consultation "return home" between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
current standard of care
connection documentation faxed to GP (General practitioner) on the day of patient's discharge
CREDO standard of care
organized consultation "return home" between patient, GP DESC (diploma of complementary specialized study) and patient's referent GP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject hospitalized in an oncology dedicated center for administration of the first chemotherapy cycle.
3. Subject with metastatic solid tumor whatever the organ
4. subject planned to be discharged home after chemotherapy administration
5. Affiliated to the French social security system.
6. Subjects must provide written informed consent prior to any study-specific procedure or assessment
Exclusion Criteria
2. Pregnant or breastfeedings women
3. Subject law protected
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Claudius Regaud
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie-Eve ROUGE BUGAT, MD
Role: PRINCIPAL_INVESTIGATOR
Institut Claudius Regaud
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Auch
Auch, , France
Hopital Rangueil
Toulouse, , France
Institut Claudius Regaud
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gimenez L, Grosclaude P, Druel V, Costa N, Delpierre C, Molinier L, Delord JP, Rouge Bugat ME. Study protocol of the CREDO randomised controlled trial: evaluation of a structured return home consultation for patients suffering from metastaticcancer. BMJ Open. 2023 Jan 30;13(1):e062219. doi: 10.1136/bmjopen-2022-062219.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16GENE11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.